BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2852842)

  • 1. [Survey of the dopaminergic synapse].
    Costentin J
    Rev Prat; 1988 Oct; 38(25 Suppl):5-9. PubMed ID: 2852842
    [No Abstract]   [Full Text] [Related]  

  • 2. Bilateral processing in chemical synapses with electrical 'ephaptic' feedback: a theoretical model.
    Savtchenko LP
    Math Biosci; 2007 May; 207(1):113-37. PubMed ID: 17112549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of MAO in dopaminergic transmission.
    Riederer P; Konradi C; Youdim MB
    Adv Neurol; 1990; 53():149-53. PubMed ID: 2173368
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of dopamine receptors in regulating glutamatergic synaptic transmission in the rat neostriatum].
    Godukhin OV; Zharikova AD; Zakharova LI
    Fiziol Zh SSSR Im I M Sechenova; 1981 Mar; 67(3):384-9. PubMed ID: 6113995
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-synaptic intercellular communication: presynaptic inhibition.
    Vizi ES
    Acta Biol Acad Sci Hung; 1982; 33(2-3):331-51. PubMed ID: 6129764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of adrenoreceptors in regulating the efficiency of adrenergic synaptic transmission].
    Bazian AS
    Usp Sovrem Biol; 1981; 92(1):115-26. PubMed ID: 6270927
    [No Abstract]   [Full Text] [Related]  

  • 7. Modulation of synaptic excitability introduction.
    Weight FF
    Fed Proc; 1979 Jun; 38(7):2078-9. PubMed ID: 221266
    [No Abstract]   [Full Text] [Related]  

  • 8. [The role of norepinephrine and dopamine in synaptic transmission of vegetative ganglions].
    Kadzielawa K
    Acta Physiol Pol; 1972; 23():81-95. PubMed ID: 4338738
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine and schizophrenia.
    Ashby B
    Nature; 1990 Dec; 348(6301):493. PubMed ID: 2174127
    [No Abstract]   [Full Text] [Related]  

  • 10. A fresh look at dopamine.
    Cools AR
    Biol Psychiatry; 1981 Oct; 16(10):903-5. PubMed ID: 6272886
    [No Abstract]   [Full Text] [Related]  

  • 11. [Presynaptic receptors and modulation of neurotransmitter release].
    Langer SZ
    J Pharmacol; 1982; 13 Suppl 1():45-52. PubMed ID: 6125629
    [No Abstract]   [Full Text] [Related]  

  • 12. [Roles of cyclic nucleotides in synaptic functions].
    Kobayashi H
    Tanpakushitsu Kakusan Koso; 1984 Nov; 29(12 Suppl):1240-53. PubMed ID: 6098923
    [No Abstract]   [Full Text] [Related]  

  • 13. The morphology of excitatory central synapses: from structure to function.
    Rollenhagen A; Lübke JH
    Cell Tissue Res; 2006 Nov; 326(2):221-37. PubMed ID: 16932936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptic and non-synaptic striatal dopamine D2 receptors: possible implications in normal and pathological behaviour.
    Korf J; Loopuijt LD
    Acta Morphol Neerl Scand; 1988-1989; 26(2-3):177-90. PubMed ID: 2908162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphetamine depresses excitatory synaptic transmission at prefrontal cortical layer V synapses.
    Mair RD; Kauer JA
    Neuropharmacology; 2007 Jan; 52(1):193-9. PubMed ID: 16895728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of calcium ions in increasing the efficiency of synaptic transmission].
    Andriiashik DIu
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1981; (1):14-8. PubMed ID: 6113855
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopaminergic activation of Fos and the rat model of Parkinson's disease.
    Cole DG
    Adv Neurol; 1993; 60():334-7. PubMed ID: 8380526
    [No Abstract]   [Full Text] [Related]  

  • 18. The complexity of the dopaminergic synapses and their modulation by antipsychotics.
    Leuner K; Müller WE
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S15-20. PubMed ID: 16508891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
    Lideman RR; Zlobina GP; Mukhin AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
    [No Abstract]   [Full Text] [Related]  

  • 20. Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of striatal drug infusions.
    Tepper JM; Nakamura S; Young SJ; Groves PM
    Brain Res; 1984 Sep; 309(2):317-33. PubMed ID: 6089960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.